Kennett G, Lightowler S, Trail B, Bright F, Bromidge S
Neurobehavioural Research, SmithKline Beecham Pharmaceuticals, New frontiers Science Park, Third Avenue, Harlow, Essex, CM19 5AW, UK.
Eur J Pharmacol. 2000 Jan 10;387(2):197-204. doi: 10.1016/s0014-2999(99)00706-2.
There is some controversy as to whether 5-HT(2C) receptor agonists are anxiogenic or anxiolytic. The effects of the novel 5-HT(2C) receptor agonist, (S)-2-chloro-5-fluoro-indol-1-yl)-1-methyl ethylamine fumarate (RO 60 0175), in three models of anxiety were therefore tested. RO 60 0175 was found to induce hypolocomotion in rats at doses greater than 0.5 mg/kg s.c., an effect reversed by the selective 5-HT(2C) receptor antagonist, SB-242084. RO 60 0175 did not elicit anxiolytic-like responses in the social interaction test under high light unfamiliar conditions, but suppressed both time spent in social interaction and locomotion at doses of 1 and 3 mg/kg s.c., suggesting a sedative response. In the Vogel conflict test, RO 60 0175 had no significant action on the number of shocks taken. In the Geller-Seifter test, RO 60 0175 (0.3 and 1 mg/kg s.c.) simultaneously reduced both unpunished and punished lever pressing, a profile consistent with sedation. Finally, RO 60 0175 was tested in a rat social interaction test under low light familiar conditions optimal for the detection of anxiogenic-like responses. At 1 and 3 mg/kg s.c., RO 60 0175 reduced both time spent in social interaction and concurrent locomotion, a profile more consistent with sedation than anxiogenesis. In conclusion, RO 60 0175 induced sedative-like responses via 5-HT(2C) receptor activation, but was neither anxiolytic, nor clearly anxiogenic at the doses tested.
关于5-羟色胺(5-HT)2C受体激动剂是致焦虑还是抗焦虑存在一些争议。因此,测试了新型5-HT2C受体激动剂富马酸(S)-2-氯-5-氟-吲哚-1-基)-1-甲基乙胺(RO 60 0175)在三种焦虑模型中的作用。发现RO 60 0175在皮下注射剂量大于0.5mg/kg时可诱导大鼠运动减少,该作用可被选择性5-HT2C受体拮抗剂SB-242084逆转。在强光陌生条件下的社交互动测试中,RO 60 0175未引发抗焦虑样反应,但在皮下注射剂量为1和3mg/kg时,既抑制了社交互动时间,也抑制了运动,提示有镇静反应。在Vogel冲突测试中,RO 60 0175对遭受电击的次数无显著作用。在Geller-Seifter测试中,RO 60 0175(皮下注射0.3和1mg/kg)同时减少了未受惩罚和受惩罚的杠杆按压,这一表现与镇静作用一致。最后,在弱光熟悉条件下的大鼠社交互动测试中对RO 60 0175进行了测试,该条件最适合检测致焦虑样反应。在皮下注射剂量为1和3mg/kg时,RO 60 0175减少了社交互动时间和同时发生的运动,这一表现更符合镇静作用而非致焦虑作用。总之,RO 60 0175通过5-HT2C受体激活诱导了镇静样反应,但在所测试的剂量下既不是抗焦虑药,也没有明显的致焦虑作用。